AQ Lab beta testing completed and the platform is ready for commercial deployment
After a year of development and a few months of final beta testing, AQ Lab is ready to be deployed as a research and development platform for E-TRF and biosensor-based projects.
Aqsens Health starting pre-clinical trials for urinary tract cancer detection in China
Aqsens Health and its Chinese partner OG Pharmaceuticals have received funding for a joint prostate and bladder cancer pre-clinical and clinical research project in Jiangsu Province in China.
Aqsens Health, Tyks and Auria Biobank join forces for a research study to detect and classify bladder cancer with phage-biosensors
Aqsens Health, Turku University Hospital (Tyks) and Auria Biobank join forces for a bladder cancer research study. This local research collaboration aims to see whether Aqsens Health’s biosensors can be used in the detection and classification of bladder cancer, focusing especially on non-invasive monitoring of bladder cancer tumor development, relapse, and recurrence.
BIOSALIVA – Aqsens Health and Shanghai Jiao Tong University begin research on early detection of lung cancer and tuberculosis
Aqsens Health and research teams from the Shanghai Jiao Tong University and Shanghai Public Health Clinical Center have received research funding from China’s Ministry of Science and Technology and Business Finland to start a research collaboration focusing on the detection of lung cancer and tuberculosis from saliva samples.
Aqsens Health and Turku University Hospital begin a project to assess a novel biosensor method for the early detection of metastatic cancers
Aqsens Health Oy begins a new research collaboration to assess the biosensor method in the detection of different metastatic cancers using urine samples. The BIOURICA research study brings together Aqsens Health Oy’s scientific team and the Turku University Hospital (TYKS) researcher, adjunct professor and Clinical Oncologist Maria Sundvall.
